Home
- Meeting Archive
- Leadership
Coalition Activities
Community Tools
Provider Resources
- Guidelines
- Training & Continuing Medical Education
Join
- Weekly Newsletter

New Hep C Drugs

Published by HepCAP on September 27, 2017September 27, 2017

HCVAdvocate.org posted news about another cheaper Hep C drug. Hopefully the market will continue to compete the prices down!

Learn more about the FDA drug pipline at http://hcvadvocate.org/treatment/drug-pipeline/#FDA

Mavyret

Categories: Treatment

Events

Event: The “Heppy” Hour: A Mocktail Fundraiser for FIGHT’s C A Difference (7/25)

Thursday, July 25th 2019 5:30 PM – 7:30 PM Broad Street Ministry (315 S. Broad Street) Join the effort to eliminate Hepatitis C in Philadelphia. In honor of World Hepatitis Day, Philadelphia FIGHT Community Health Centers welcomes Read more…

Events

Webinar: Hepatitis B and the Opioid Epidemic: Opportunities to Increase Adult Vaccination (AAPCHO) (7/30)

July 30th, 2019, 3:00pm ET Learn about Hepatitis B and the Opioid Epidemic, and about the importance of increasing efforts to address hepatitis B vaccination and awareness, in this AAPCHO webinar! Learn more and register Read more…

News

News: FDA approves first treatment for all genotypes of hepatitis C in pediatric patients

View the April 30 press release from the FDA here. The U.S. Food and Drug Administration approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages Read more…

Home
Coalition Activities
Community Tools
Provider Resources
Join

Hestia | Developed by ThemeIsle

New Hep C Drugs

Published by HepCAP on September 27, 2017September 27, 2017

Related Posts

Event: The “Heppy” Hour: A Mocktail Fundraiser for FIGHT’s C A Difference (7/25)

Webinar: Hepatitis B and the Opioid Epidemic: Opportunities to Increase Adult Vaccination (AAPCHO) (7/30)

News: FDA approves first treatment for all genotypes of hepatitis C in pediatric patients